Towards a unified vision of copper involvement in Alzheimer's disease: A review connecting basic, experimental, and clinical research

Journal of Alzheimer's Disease

Volumn 44, Issue 2, 2015, Pages 343-354

  Pal, Amit ^a   Siotto, Mariacristina ^b   Prasad, Rajendra ^a   Squitti, Rosanna ^c,d  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

^c FATEBENEFRATELLI HOSPITAL   (Italy)

^d IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

Alzheimer's disease; ceruloplasmin; copper; metal; subtype

Indexed keywords

COPPER; DRINKING WATER;

ALZHEIMER DISEASE; BRAIN LEVEL; CENTRAL NERVOUS SYSTEM; CLINICAL RESEARCH; COGNITIVE DEFECT; COPPER METABOLISM; DIETARY INTAKE; DISEASE ASSOCIATION; DISEASE COURSE; FOOD COMPOSITION; GENETIC RISK; HEAVY METAL POISONING; HOMEOSTASIS; HUMAN; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SUSCEPTIBLE POPULATION; ANIMAL; BRAIN; GENETICS; METABOLISM;

ALZHEIMER DISEASE; ANIMALS; BRAIN; COPPER; HUMANS;

EID: 84921442424     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-141194     Document Type: Review

References (83)

1. Turnlund JR (1998) Human whole-body copper metabolism. Am J Clin Nutr 67, 960S-964S.
2. Squitti R, Siotto M, Polimanti R (2014) Low-copper diet as a preventive strategy for Alzheimer's disease. Neurobiol Aging. 2014 Sep; 35 Suppl 2:S40-S50. doi: 10.1016/j.neurobiolaging.2014.02.031. Epub 2014 May 15. Review. PubMed PMID: 24913894.
3. Squitti R, Polimanti R (2012) Copper hypothesis in the missing hereditability of sporadic Alzheimer's disease: ATP7B gene as potential harbor of rare variants. J Alzheimers Dis 29, 493-501.
4. Squitti R, Polimanti R (2013) Copper phenotype in Alzheimer's disease: Dissecting the pathway. Am J Neurodegener Dis 2, 46-56.
5. Squitti R, Siotto M, Polimanti R (2014) Low-copper diet as a preventive strategy for Alzheimer's disease. Neurobiol Aging 35(Suppl 2), S40-S50.
6. Crisponi G, Nurchi VM, Fanni D, Gerosa C, Nemolato S, Faa G (2010) Copper-related diseases: From chemistry to molecular pathology. Coord Chem Rev 254, 876-889.
7. Madsen E, Gitlin JD (2007) Copper and iron disorders of the brain. Annu Rev Neurosci 30, 317-337.
8. Cox DW, Moore SD (2002) Copper transporting P-type ATPases and human disease. J Bioenerg Biomembr 34, 333-338.
9. Mehta R, Templeton DM, O'Brien PJ (2006) Mitochondrial involvement in genetically determined transition metal toxicity II. Copper toxicity. Chem Biol Interact 163, 77-85.
10. Georgopoulos PG, Roy A, Yonone-Lioy MJ, Opiekun RE, Lioy PJ (2001) Environmental copper: Its dynamics and human exposure issues. J Toxicol Environ Health B Crit Rev 4, 341-394.
11. Sayre LM, Perry G, Smith MA (1999) Redox metals and neurodegenerative disease. Curr Opin Chem Biol 3, 220-225.
12. Prasad R, Kaur G, Nath R,Walia BN (1996) Molecular basis of pathophysiology of Indian childhood cirrhosis: Role of nuclear copper accumulation in liver. Mol Cell Biochem 156, 25-30.
13. Braughler JM, Hall ED(1989) Central nervous system trauma and stroke. I. Biochemical considerations for oxygen radical formation and lipid peroxidation. Free Radic Biol Med 6, 289-301.
14. Carri MT, Ferri A, Cozzolino M, Calabrese L, Rotilio G (2003) Neurodegeneration in amyotrophic lateral sclerosis: The role of oxidative stress and altered homeostasis of metals. Brain Res Bull 61, 365-374.
15. Ozcelik D, Uzun H (2009) Copper intoxication; antioxidant defenses and oxidative damage in rat brain. Biol Trace Elem Res 127, 45-52.
16. Desai V, Kaler SG (2008) Role of copper in human neurological disorders. Am J Clin Nutr 88, 855S-858S.
17. Zheng W, Monnot AD (2012) Regulation of brain iron and copper homeostasis by brain barrier systems: Implication in neurodegenerative diseases. Pharmacol Ther 133, 177-188.
18. Kozlowski H, Luczkowski M, Remelli M, Valensin D. Copper, zinc and iron in neurodegenerative diseases (Alzheimer's, Parkinson's and prion diseases). Coord Chem Rev 256, 2129-2141.
19. Jomova K,Vondrakova D,Lawson M,Valko M(2010) Metals, oxidative stress and neurodegenerative disorders. Mol Cell Biochem 345, 91-104.
20. Tiffany-Castiglioni E, Hong S, Qian Y (2011) Copper handling by astrocytes: Insights into neurodegenerative diseases. Int J Dev Neurosci 29, 811-818.
21. Roberts EA, Schilsky ML, American Association for Study of Liver D (2008) Diagnosis and treatment ofWilson disease: An update. Hepatology 47, 2089-2111.
22. Ballatore C, Lee VM, Trojanowski JQ (2007) Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat Rev Neurosci 8, 663-672.
23. LaFerla FM, Green KN, Oddo S (2007) Intracellular amyloidbeta in Alzheimer's disease. Nat Rev Neurosci 8, 499-509.
24. Brewer GJ (2009) The risks of copper toxicity contributing to cognitive decline in the aging population and to Alzheimer's disease. J Am Coll Nutr 28, 238-242.
25. Squitti R, Barbati G, Rossi L, Ventriglia M, Dal Forno G, Cesaretti S, Moffa F, Caridi I, Cassetta E, Pasqualetti P, Calabrese L, Lupoi D, Rossini PM (2006) Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF [beta]-amyloid, and h-tau. Neurology 67, 76-82.
26. Squitti R, Bressi F, Pasqualetti P, Bonomini C, Ghidoni R, Binetti G, Cassetta E, Moffa F, Ventriglia M, Vernieri F, Rossini PM (2009) Longitudinal prognostic value of serum "free" copper in patients with Alzheimer disease. Neurology 72, 50-55.
27. Capo CR, Arciello M, Squitti R, Cassetta E, Rossini PM, Calabrese L, Rossi L (2008) Features of ceruloplasmin in the cerebrospinal fluid of Alzheimer's disease patients. Biometals 21, 367-372.
28. Squitti R, Quattrocchi CC, Salustri C, Rossini PM (2008) Ceruloplasmin fragmentation is implicated in 'free' copper deregulation of Alzheimer's disease. Prion 2, 23-27.
29. Amtage F, Birnbaum D, Reinhard T, Niesen W, Weiller C, Mader I, Meyer P, RijntjesM(2014) Estrogen intake and copper depositions: Implications for Alzheimer's disease? Case Rep Neurol 6, 181-187.
30. Atwood CS, Moir RD, Huang X, Scarpa RC, Bacarra NM, Romano DM, Hartshorn MA, Tanzi RE, Bush AI (1998) Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis. J Biol Chem 273, 12817-12826.
31. Huang HC, Jiang ZF. Amyloid-beta protein precursor family members: A review from homology to biological function. J Alzheimers Dis 26, 607-626.
32. Huang X, Atwood CS, Hartshorn MA,Multhaup G, Goldstein LE, Scarpa RC, Cuajungco MP, Gray DN, Lim J, Moir RD, Tanzi RE, Bush AI (1999) The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 38, 7609-7616.
33. Huang X, Cuajungco MP, Atwood CS, Hartshorn MA, Tyndall JD, Hanson GR, Stokes KC, Leopold M, Multhaup G, Goldstein LE, Scarpa RC, Saunders AJ, Lim J, Moir RD, Glabe C, Bowden EF,Masters CL, Fairlie DP, Tanzi RE, Bush AI (1999) Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. J Biol Chem 274, 37111-37116.
34. White AR, Multhaup G, Maher F, Bellingham S, Camakaris J, Zheng H, Bush AI, Beyreuther K, Masters CL, Cappai R (1999) The Alzheimer's disease amyloid precursor protein modulates copper-induced toxicity and oxidative stress in primary neuronal cultures. J Neurosci 19, 9170-9179.
35. White AR, Reyes R, Mercer JF, Camakaris J, Zheng H, Bush AI, Multhaup G, Beyreuther K, Masters CL, Cappai R (1999) Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice. Brain Res 842, 439-444.
36. Cherny RA, Legg JT, McLean CA, Fairlie DP, Huang X, Atwood CS, Beyreuther K, Tanzi RE, Masters CL, Bush AI (1999) Aqueous dissolution of Alzheimer's disease Abeta amyloid deposits by biometal depletion. J Biol Chem 274, 23223-23228.
37. Sparks DL, Schreurs BG (2003) Trace amounts of copper in water induce beta-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease. Proc Natl Acad SciUS A 100, 11065-11069.
38. Nelson TJ, Alkon DL(2005) Oxidation of cholesterol by amyloid precursor protein and beta-amyloid peptide. J Biol Chem 280, 7377-7387.
39. Sparks DL, Friedland R, Petanceska S, Schreurs BG, Shi J, Perry G, Smith MA, Sharma A, Derosa S, Ziolkowski C, Stankovic G (2006) Trace copper levels in the drinking water, but not zinc or aluminum influence CNS Alzheimerlike pathology. J Nutr Health Aging 10, 247-254.
40. Lu J, Zheng YL, Wu DM, Sun DX, Shan Q, Fan SH (2006) Trace amounts of copper induce neurotoxicity in the cholesterol-fed mice through apoptosis. FEBS Lett 580, 6730-6740.
41. MaoX,Ye J, Zhou S, Pi R, Dou J, Zang L, Chen X, Chao X, Li W, Liu M, Liu P (2012) The effects of chronic copper exposure on the amyloid protein metabolisim associated genes' expression in chronic cerebral hypoperfused rats. Neurosci Lett 518, 14-18.
42. Brewer GJ (2008) The risks of free copper in the body and the development of useful anticopper drugs. Curr Opin Clin Nutr Metab Care 11, 727-732.
43. Singh I, Sagare AP, Coma M, Perlmutter D, Gelein R, Bell RD, Deane RJ, Zhong E, Parisi M, Ciszewski J, Kasper RT, Deane R (2013) Low levels of copper disrupt brain amyloidbeta homeostasis by altering its production and clearance. Proc Natl Acad Sci U S A 110, 14771-14776.
44. Brewer GJ (2011) Issues raised involving the copper hypotheses in the causation of Alzheimer's disease. Int J Alzheimers Dis 2011, 537528.
45. Multhaup G, Schlicksupp A, Hesse L, Beher D, Ruppert T, Masters CL, Beyreuther K(1996) The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I). Science 271, 1406-1409.
46. White AR, Multhaup G, Galatis D, McKinstry WJ, Parker MW, Pipkorn R, Beyreuther K, Masters CL, Cappai R (2002) Contrasting, species-dependent modulation of coppermediated neurotoxicity by the Alzheimer's disease amyloid precursor protein. J Neurosci 22, 365-376.
47. Parthasarathy S, Yoo B, McElheny D, Tay W, Ishii Y (2014) Capturing a reactive state of amyloid aggregates: NMR-based characterization of copper-bound Alzheimer disease amyloid beta-fibrils in a redox cycle. J Biol Chem 289, 9998-10010.
48. Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR (1998) Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci 158, 47-52.
49. Schrag M, Mueller C, Oyoyo U, Smith MA, Kirsch WM.Iron, zinc and copper in the Alzheimer's disease brain: A quantitative meta-analysis. Some insight on the influence of citation bias on scientific opinion. Prog Neurobiol 94, 296-306.
50. Graham SF, Nasaruddin MB, CareyM, Holscher C, McGuinness B, Kehoe PG, Love S,Passmore P, Elliott CT, Meharg AA, GreenBD(2014) Age-Associated Changes of Brain Copper, Iron, and Zinc in Alzheimer's Disease and Dementia with Lewy Bodies. J Alzheimers Dis Jul 11. [Epub ahead of print] PubMed PMID: 25024342.
51. Rembach A, Hare DJ, Lind M, Fowler CJ, Cherny RA, McLean C, Bush AI, Masters CL, Roberts BR (2013) Decreased copper in Alzheimer's disease brain is predominantly in the soluble extractable fraction. Int J Alzheimers Di 2013, 623241.
52. Fujiwara N, Iso H, Kitanaka N, Kitanaka J, Eguchi H, Ookawara T, Ozawa K, Shimoda S, Yoshihara D, Takemura M, Suzuki K (2006) Effects of copper metabolism on neurological functions in Wistar and Wilson's disease model rats. Biochem Biophys Res Commun 349, 1079-1086.
53. James SA, Volitakis I, Adlard PA, Duce JA, Masters CL, Cherny RA, Bush AI (2012) Elevated labile Cu is associated with oxidative pathology in Alzheimer disease. Free Radic Biol Med 52, 298-302.
54. Arnal N, Cristalli DO, de Alaniz MJ, Marra CA. Clinical utility of copper, ceruloplasmin, and metallothionein plasma determinations in human neurodegenerative patients and their first-degree relatives. Brain Res 1319, 118-130.
55. Lopez N, Tormo C, De Blas I, Llinares I, Alom J (2013) Oxidative stress in Alzheimer's disease and mild cognitive impairment with high sensitivity and specificity. J Alzheimers Dis 33, 823-829.
56. Squitti R, Simonelli I, Ventriglia M, Siotto M, Pasqualetti P, Rembach A, Doecke J, Bush AI (2014) Meta-analysis of serum non-ceruloplasmin copper in Alzheimer's disease. J Alzheimers Dis 38, 809-822.
57. Schrag M, Mueller C, Zabel M, Crofton A, Kirsch WM, Ghribi O, Squitti R, Perry G (2013) Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: A meta-analysis. Neurobiol Dis 59, 100-110.
58. Morris MC, Evans DA, Tangney CC, Bienias JL, Schneider JA,Wilson RS, Scherr PA(2006) Dietary copper and high saturated and trans fat intakes associated with cognitive decline. Arch Neurol 63, 1085-1088.
59. Jacobs D, Oxley DK, DeMott WR (2002) Laboratory Test Handbook: Concise with Disease Index, 2nd ed., Lexi-Comp, Hudson, OH.
60. Walshe JM, Clinical Investigations Standing Committee of the Association of Clinical B (2003) Wilson's disease: The importance of measuring serum caeruloplasmin nonimmunologically. Ann Clin Biochem 40, 115-121.
61. Squitti R, Pasqualetti P, Dal Forno G, Moffa F, Cassetta E, Lupoi D, Vernieri F, Rossi L, Baldassini M, Rossini PM (2005) Excess of serum copper not related to ceruloplasmin in Alzheimer disease. Neurology 64, 1040-1046.
62. Squitti R, Lupoi D, Pasqualetti P, Dal Forno G, Vernieri F, Chiovenda P, Rossi L, Cortesi M, Cassetta E, Rossini PM (2002) Elevation of serum copper levels in Alzheimer's disease. Neurology 59, 1153-1161.
63. Squitti R, Ghidoni R, Scrascia F, Benussi L, Panetta V, Pasqualetti P, Moffa F, Bernardini S, Ventriglia M, Binetti G, Rossini PM (2011) Free copper distinguishes mild cognitive impairment subjects from healthy elderly individuals. J Alzheimers Dis 23, 239-248.
64. Squitti R, Ghidoni R, Siotto M,Ventriglia M, Benussi L, Paterlini A, Magri M, Binetti G, Cassetta E, Caprara D, Vernieri F, Rossini PM, Pasqualetti P (2014) Value of serum nonceruloplasmin copper for prediction of mild cognitive impairment conversion to Alzheimer disease. Ann Neurol 75, 574-580.
65. Murray ME, Graff-Radford NR, Ross OA, Petersen RC, Duara R, Dickson DW (2011) Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: A retrospective study. Lancet Neurol 10, 785-796.
66. Bucossi S, Mariani S, Ventriglia M, Polimanti R, Gennarelli M, Bonvicini C, Pasqualetti P, Scrascia F, Migliore S,Vernieri F, Rossini PM, Squitti R (2011) Association between the c. 2495 A>G ATP7B polymorphism and sporadic Alzheimer's disease. Int J Alzheimers Dis 2011, 973692s.
67. Bucossi S, Polimanti R, Mariani S,Ventriglia M, Bonvicini C, Migliore S, Manfellotto D, Salustri C,Vernieri F, Rossini PM, Squitti R (2012) Association of K832R and R952K SNPs of Wilson's disease gene with Alzheimer's disease. J Alzheimers Dis 29, 913-919.
68. Bucossi S, Polimanti R, Ventriglia M, Mariani S, Siotto M, Ursini F, Trotta L, Scrascia F, Callea A, Vernieri F, Squitti R (2013) Intronic rs2147363 variant in ATP7B transcription factor-binding site associated with Alzheimer's disease. J Alzheimers Dis 37, 453-459.
69. Squitti R, Polimanti R, Bucossi S, Ventriglia M, Mariani S, Manfellotto D, Vernieri F, Cassetta E, Ursini F, Rossini PM (2013) Linkage disequilibrium and haplotype analysis of the ATP7B gene in Alzheimer's disease. Rejuvenation Res 16, 3-10.
70. Squitti R, Polimanti R, Siotto M, Bucossi S, Ventriglia M, Mariani S, Vernieri F, Scrascia F, Trotta L, Rossini PM (2013) ATP7B variants as modulators of copper dyshomeostasis in Alzheimer's disease. Neuromolecular Med 15, 515-522.
71. Bucossi S, Ventriglia M, Panetta V, Salustri C, Pasqualetti P, Mariani S, Siotto M, Rossini PM, Squitti R. Copper in Alzheimer's disease: A meta-analysis of serum,plasma, and cerebrospinal fluid studies. J Alzheimers Dis 24, 175-185.
72. Schrag M, Mueller C, Zabel M, Crofton A, Kirsch WM, Ghribi O, Squitti R, Perry G. Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: A metaanalysis. Neurobiol Dis 59, 100-110.
73. Ventriglia M, Bucossi S, Panetta V, Squitti R. Copper in Alzheimer's disease: A meta-analysis of serum, plasma, and cerebrospinal fluid studies. J Alzheimers Dis 30, 981-984.
74. Salustri C, Barbati G, Ghidoni R, Quintiliani L, Ciappina S, Binetti G, Squitti R (2010) Is cognitive function linked to serum free copper levels? A cohort study in a normal population. Clin Neurophysiol 121, 502-507.
75. Liu HP, Lin WY, Wang WF, Tsai CH, Wu WC, Chiou MT, Shen CP,Wu BT, Tsai FJ (2013) Genetic variability in coppertransporting P-type adenosine triphosphatase (ATP7B) is associated with Alzheimer's disease in a Chinese population. J Biol Regul Homeost Agents 27, 319-327.
76. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Menezes PR, Rimmer E, Scazufca M, Alzheimer's Disease I (2005) Global prevalence of dementia: A Delphi consensus study. Lancet 366, 2112-2117.
77. WHO (1996) Copper. In Trace Elements in Human Nutrition and Health.World Health Organization, Geneva, pp. 123-143.
78. WHO (2004) Copper. In Copper in Drinking-water. World Health Organization, Geneva, pp. 1-23.
79. Mursu J, Robien K, Harnack LJ, Park K, Jacobs DR Jr (2011) Dietary supplements and mortality rate in older women: The Iowa Women's Health Study. Arch Intern Med 171, 1625-1633.
80. Shen XL, Yu JH, Zhang DF, Xie JX, Jiang H (2014) Positive relationship between mortality from Alzheimer's disease and soil metal concentration in mainland China. J Alzheimers Dis 42, 893-900.
81. Siaj R, Sauer V, Stoppeler S, Spiegel HU, Kohler G, Zibert A, Schmidt HH (2012) Dietary copper triggers onset of fulminant hepatitis in the Long-Evans cinnamon rat model. World J Gastroenterol 18, 5542-5550.
82. Barnard ND, Bush AI, Ceccarelli A, Cooper J, de Jager CA, Erickson KI, Fraser G, Kesler S, Levin SM, Lucey B, Morris MC, Squitti R (2014) Dietary and lifestyle guidelines for the prevention of Alzheimer's disease. Neurobiol Aging 3552, S74-S78.
83. Pal A, Kumar A, Prasad R (2014) Predictive association of copper metabolism proteins with Alzheimer's disease and Parkinson's disease:Apreliminary perspective. Biometals 27, 25-31.